Daniel O’Day, Chairman & CEO, Gilead Sciences, recently sent an open letter to the American Public, indicating why its U.S. Patented drug Remdesivir to treat the coronavirus will be a company $$ bonanza with its new pricing. Because of the way the U.S. system is set up and the discounts that government healthcare programs expect, … Continue reading Gilead coronavirus drug is $3,100. We can’t purchase India’s generic for 1/4 the price!